These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15994669)

  • 1. Israeli doctors want to stop European patent for genetic test.
    Siegel-Itzkovich J
    BMJ; 2005 Jul; 331(7507):8. PubMed ID: 15994669
    [No Abstract]   [Full Text] [Related]  

  • 2. [Predisposition to breast cancer: Europe closes its doors to Myriad Genetics (Salt Lake City)].
    Nau JY
    Rev Med Suisse; 2007 Oct; 3(128):2320. PubMed ID: 17985613
    [No Abstract]   [Full Text] [Related]  

  • 3. [Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2005; 21(6-7):658-62. PubMed ID: 15985212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data disclosure crucial after DNA patent verdict.
    de Costa A
    Science; 2013 Aug; 341(6149):959. PubMed ID: 23990544
    [No Abstract]   [Full Text] [Related]  

  • 5. Patents on breast cancer genes are illegal and stymie research, say scientists.
    Lenzer J
    BMJ; 2009 Nov; 339():b4899. PubMed ID: 19920010
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic patent singles out Jewish women.
    Abbott A
    Nature; 2005 Jul; 436(7047):12. PubMed ID: 16001030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
    Stoppa-Lyonnet D; Lenoir G
    Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
    [No Abstract]   [Full Text] [Related]  

  • 8. Testing time for gene patents.
    Nature; 2010 Apr; 464(7291):957. PubMed ID: 20393513
    [No Abstract]   [Full Text] [Related]  

  • 9. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
    Paradise J
    Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
    [No Abstract]   [Full Text] [Related]  

  • 10. French researchers take a stand against cancer gene patent.
    Butler D; Goodman S
    Nature; 2001 Sep; 413(6852):95-6. PubMed ID: 11557932
    [No Abstract]   [Full Text] [Related]  

  • 11. Supreme Court ruling broadens BRCA testing options.
    Azvolinsky A
    J Natl Cancer Inst; 2013 Nov; 105(22):1671-2. PubMed ID: 24198329
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there still a place for gene patents in Australia? Implications of recent United States and European case law.
    Ridley A; Nicol D
    J Law Med; 2011 Dec; 19(2):282-99. PubMed ID: 22320004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malta provides loophole for breast-cancer screen.
    Check E
    Nature; 2002 Oct; 419(6909):767. PubMed ID: 12397316
    [No Abstract]   [Full Text] [Related]  

  • 14. [Federal judge and government of the United States against gene patenting].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
    [No Abstract]   [Full Text] [Related]  

  • 15. Patenting of genetic material: are the benefits to society being realized?
    Willison DJ; MacLeod SM
    CMAJ; 2002 Aug; 167(3):259-62. PubMed ID: 12186174
    [No Abstract]   [Full Text] [Related]  

  • 16. Your money or your life.
    Westphal SP
    New Sci; 2002 Jul; 175(2351):28-33. PubMed ID: 12625339
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene patenting--is the pendulum swinging back?
    Kesselheim AS; Mello MM
    N Engl J Med; 2010 May; 362(20):1855-8. PubMed ID: 20375396
    [No Abstract]   [Full Text] [Related]  

  • 18. Europe's patent rebellion.
    Wadman M
    Fortune; 2001 Oct; 144(6):44. PubMed ID: 11586878
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
    Abbot J
    J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From intellectual property to commercial property].
    Cappelaere P
    Bull Cancer; 2005 Apr; 92(4):297-8. PubMed ID: 15888384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.